4//SEC Filing
Nabulsi Azmi 4
Accession 0000950170-24-084186
CIK 0001783183other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 2:52 PM ET
Size
6.3 KB
Accession
0000950170-24-084186
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-07-15$11.72/sh−10,901$127,760→ 240,421 total
Holdings
- 785,700(indirect: By Trust)
Common Stock
- 3,578.93(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F2]Includes 1,754 shares acquired in January 2024 and 1 share acquired in July 2024 under the Phathom Pharmaceuticals, Inc. employee stock purchase plan
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 2:52 PM ET
- Size
- 6.3 KB